Alto Neuroscience Stock Price Prediction
| ANRO Stock | 16.81 0.40 2.44% |
Momentum 52
Impartial
Oversold | Overbought |
Using Alto Neuroscience hype-based prediction, you can estimate the value of Alto Neuroscience from the perspective of Alto Neuroscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Alto Neuroscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Alto because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Alto Neuroscience after-hype prediction price | USD 16.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Alto Neuroscience Basic Forecasting Models to cross-verify your projections. Alto Neuroscience After-Hype Price Density Analysis
As far as predicting the price of Alto Neuroscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alto Neuroscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alto Neuroscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alto Neuroscience Estimiated After-Hype Price Volatility
In the context of predicting Alto Neuroscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alto Neuroscience's historical news coverage. Alto Neuroscience's after-hype downside and upside margins for the prediction period are 11.02 and 22.60, respectively. We have considered Alto Neuroscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alto Neuroscience is somewhat reliable at this time. Analysis and calculation of next after-hype price of Alto Neuroscience is based on 3 months time horizon.
Alto Neuroscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Alto Neuroscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alto Neuroscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alto Neuroscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 5.79 | 0.00 | 0.02 | 0 Events / Month | 3 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
16.81 | 16.81 | 0.00 |
|
Alto Neuroscience Hype Timeline
Alto Neuroscience is presently traded for 16.81. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Alto is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.47%. %. The volatility of related hype on Alto Neuroscience is about 17029.41%, with the expected price after the next announcement by competition of 16.83. About 66.0% of the company shares are held by institutions such as insurance companies. The book value of Alto Neuroscience was presently reported as 4.11. The company recorded a loss per share of 2.3. Alto Neuroscience had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Alto Neuroscience Basic Forecasting Models to cross-verify your projections.Alto Neuroscience Related Hype Analysis
Having access to credible news sources related to Alto Neuroscience's direct competition is more important than ever and may enhance your ability to predict Alto Neuroscience's future price movements. Getting to know how Alto Neuroscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alto Neuroscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CLLS | Cellectis SA | 0.00 | 0 per month | 4.37 | 0.06 | 9.24 | (7.69) | 29.31 | |
| ACIU | AC Immune | 0.00 | 0 per month | 0.00 | (0.02) | 7.01 | (8.36) | 26.05 | |
| AMRN | Amarin PLC | 0.18 | 8 per month | 0.00 | (0.1) | 4.89 | (4.37) | 21.26 | |
| LRMR | Larimar Therapeutics | 0.07 | 9 per month | 5.10 | (0.02) | 6.96 | (7.49) | 21.85 | |
| CTNM | Contineum Therapeutics Class | 0.52 | 10 per month | 3.97 | 0.08 | 7.99 | (5.55) | 23.16 | |
| ALDX | Aldeyra | 0.00 | 0 per month | 4.44 | 0.04 | 6.27 | (8.84) | 42.93 | |
| DRTS | Alpha Tau Medical | 0.00 | 0 per month | 3.47 | 0.19 | 10.48 | (6.42) | 28.89 | |
| SLN | Silence Therapeutics PLC | (0.03) | 8 per month | 0.00 | (0.13) | 6.88 | (5.89) | 22.91 | |
| KRRO | Frequency Therapeutics | 0.00 | 0 per month | 0.00 | (0.07) | 10.98 | (6.62) | 91.55 | |
| DBVT | DBV Technologies | (0.40) | 9 per month | 3.77 | 0.13 | 10.53 | (6.81) | 36.36 |
Alto Neuroscience Additional Predictive Modules
Most predictive techniques to examine Alto price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alto using various technical indicators. When you analyze Alto charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Alto Neuroscience Predictive Indicators
The successful prediction of Alto Neuroscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alto Neuroscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alto Neuroscience based on analysis of Alto Neuroscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alto Neuroscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alto Neuroscience's related companies.
Pair Trading with Alto Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Alto Stock
| 0.59 | FNMFO | Federal National Mortgage | PairCorr |
| 0.56 | GRLF | Green Leaf Innovations | PairCorr |
| 0.43 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.41 | PKKFF | Tenet Fintech Group | PairCorr |
The ability to find closely correlated positions to Alto Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience to buy it.
The correlation of Alto Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alto Neuroscience Basic Forecasting Models to cross-verify your projections. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alto Neuroscience is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience's market value can be influenced by many factors that don't directly affect Alto Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.